期刊文献+

北京市2010年麻疹减毒活疫苗补充免疫活动前后麻疹流行病学特征变化 被引量:20

Epidemiology Characteristics of Measles before and after Supplementary Immunization Activities of Measles Attenuated Live Vaccine in Beijing in 2010
原文传递
导出
摘要 目的分析北京市2010年麻疹减毒活疫苗(Measles Attenuated LiveVaccine,MV)补充免疫活动(Supplem entary Immunization Activities,SIAs)前后麻疹流行病学特征,评价控制麻疹效果,为消除麻疹提供参考。方法利用2005~2010年麻疹逐月发病数据建立自动回归滑动平均混合模型(Autoregressive Integrated MovingAverage,ARIMA),预测2011年发病水平,采用描述流行病学方法,对北京市实施MVSIA前后麻疹监测数据进行分析。结果预测实施MVSIA前麻疹发病率为49.5/100万,实施MVSIA后麻疹发病率为5/100万,较预测水平下降89.9%。各年龄组麻疹发病率均有大幅下降,削平了季节性流行高峰。实施MVSIA后,≤4岁和15~39岁人群麻疹发病仍占较大的构成比,分别为37.8%和53.1%。结论北京市2010年实施MVSIA后,麻疹发病大幅下降。为进一步降低麻疹发病水平,应维持高水平常规免疫,提高MV及时接种率,加强学龄前散居儿童和成人查漏补种,最大程度提高免疫水平。 Objective To analyze the epidemiology characteristics of measles before and after measles attenuated live vaccine (MV) supplementary immunization activities (SIAs) in Beijing in 2010, evaluate the effectiveness of MV SIA and provide the basis for elimination of measles. Methods Autoregressive integrated moving average (ARIMA) model was developed for forecasting measles incidence in 2011. Descriptive epidemiological analysis was conducted on measles surveillance data during 2005-2011. Results Predicted measles incidence was 49.5/1,000,000 in 2011 before MV SIA. The measles incidence was 5/1,000,000 after MV SIA, descending 89.9 % compared predicted incidence. MV SIA led to the sharp drop of the measles incidence among all age groups and flatted seasonal epidemic peak. The proportion of children of ≤ 4 years and adults of 15-39 years old were 37.8 % and 53.1% after MV SIA. Conclusion MV SIA of 2010 in Beijing played a significant role for measles control. For further decreasing incidence of measles, we should strengthen routine immunization, improve timeliness of MV vaccination, and carry out SIA among the pre-school scattered children and adults.
出处 《中国疫苗和免疫》 CAS 2013年第1期31-34,74,共5页 Chinese Journal of Vaccines and Immunization
关键词 麻疹减毒活疫苗 补充免疫活动 麻疹 流行病学特征 Measles attenuated live vaccine Supplementary immunization activities Measles Epidemiology characteristics
  • 相关文献

参考文献6

二级参考文献46

  • 1左树岩,梁晓峰,殷大鹏,尤雪丹,郭飚,童亦兵,朱青,张大勇,杜雯,Lisa lee,Yoshihiro Takashima,于竞进.贵州省2003~2004年麻疹疫苗强化免疫效果评价[J].中国计划免疫,2006,12(1):7-12. 被引量:67
  • 2余文周,税铁军,李黎,梁晓峰.全国2004-2006年麻疹流行病学特征和预防控制措施分析[J].中国计划免疫,2006,12(5):337-341. 被引量:263
  • 3WHA. World Health Assembly resolution [ R ]. WHA42.32, 1989.
  • 4WHO. Measles Progress towards global control and elimination, 1990-1998[J]. WER, 1998, 50:389-394.
  • 5WHA. World Health Assembly resolution[R]. WHA56.20, 2003.
  • 6Wolfson L, et al. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study [J]. Lancet, 2007, 369:191-200.
  • 7WHO. Developed by WHO and UNICEF for the period 2006-2015 [ R ]. Available at http://www.who.int/vaccines/givs.
  • 8WHO/UNICEF. WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide [R]. WHO/V&B/01.40, 2001.
  • 9WHO/UNICEF. Measles mortality reduction and regional elimination. Strategic plan 2001-2005 [ R]. WHO, Geneva, Switzerland, 2001.
  • 10WHO. Progress in reducing global measles deaths 1999-2002[J]. WER, 2004, 3:20-21.

共引文献101

同被引文献135

引证文献20

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部